JRARX
Price
$88.22
Change
+$1.83 (+2.12%)
Updated
Jun 11 closing price
Net Assets
29.57B
RGAHX
Price
$84.29
Change
+$2.10 (+2.56%)
Updated
Jun 11 closing price
Net Assets
360.63B
Interact to see
Advertisement

JRARX vs RGAHX

Header iconJRARX vs RGAHX Comparison
Open Charts JRARX vs RGAHXBanner chart's image
JRARX vs RGAHX Comparison Chart in %
View a ticker or compare two or three
VS
JRARX vs. RGAHX commentary
Jun 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JRARX is a Hold and RGAHX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 361B vs. JRARX (29.6B). RGAHX pays higher dividends than JRARX: RGAHX (0.39) vs JRARX (0.00). JRARX was incepted earlier than RGAHX: JRARX (9 years) vs RGAHX (11 years). JRARX (1.53) is less costly to investors than RGAHX (0.44). JRARX (33.00) and RGAHX (32.00) have comparable annual turnover. RGAHX has a lower initial minimum investment than JRARX: RGAHX (250) vs JRARX (2500). RGAHX annual gain was more profitable for investors over the last year : 8.23 vs. JRARX (1.98). JRARX return over 5 years is better than : 26.08 vs. RGAHX (18.49).
JRARXRGAHXJRARX / RGAHX
Total Expense Ratio1.480.44336%
Annual Report Gross Expense Ratio1.530.44348%
Fund Existence9 years11 years-
Gain YTD1.7076.37327%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets29.6B361B8%
Annual Yield % from dividends0.000.39-
Returns for 1 year1.988.2324%
Returns for 3 years50.0946.20108%
Returns for 5 years26.0818.49141%
Returns for 10 yearsN/A108.16-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PDECX21.24N/A
N/A
PGIM Jennison Emerging Markets Eq Opps C
ALSRX18.10N/A
N/A
Alger Small Cap Growth Institutional I
MDLOX21.13N/A
N/A
BlackRock Global Allocation Inv A
TEWTX16.48N/A
N/A
Templeton World C
BRUEX17.59N/A
N/A
MFS Blended Research Value Equity B